Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?. Issue 1 (January 2021) - Howlett, S.; Harvey-Jones, E.; Smith, D.; Ahmad, S.; Goldsmith, C.; Sawyer, E.; Castell, F.; Swampillai, A.; Mullassery, V.